<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04490226</url>
  </required_header>
  <id_info>
    <org_study_id>ABW-2020-VK</org_study_id>
    <nct_id>NCT04490226</nct_id>
  </id_info>
  <brief_title>Endogenous vs. Exogenous Ketone Bodies</brief_title>
  <official_title>Impact of Endogenous vs. Exogenous Ketone Bodies on Appetite Control and Macronutrient Oxidation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kiel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kiel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to compare the origin of ketone bodies: endogenous ketone bodies due to&#xD;
      36 hours fasting or 24 hours of ketogenic diet vs. exogenous ketone bodies as supplements&#xD;
      additional to normal diet.&#xD;
&#xD;
      Secondary aim of the study is to validate the new metabolic chambers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each study week starts with a 3-day run-in period with controlled diet at home and ends with&#xD;
      a test-meal (breakfast) in the lab and following food record over the rest of the day at&#xD;
      home.&#xD;
&#xD;
        1. week: physical activity level (PAL) 1.3, 3 intervention days in the metabolic chamber:&#xD;
           ad libitum energy intake, washout day, isocaloric diet, 36 hours fasting&#xD;
&#xD;
        2. week: physical activity level (PAL) 1.3, 2 intervention days in the metabolic chamber:&#xD;
           isocaloric diet, 36 hours fasting&#xD;
&#xD;
        3. week: physical activity level (PAL) 1.6, 2 intervention days in the metabolic chamber:&#xD;
           ad libitum energy intake, 36 hours fasting&#xD;
&#xD;
        4. week: physical activity level (PAL) 1.6, 2 intervention days in the metabolic chamber:&#xD;
           isocaloric diet, ketogenic diet (isocaloric)&#xD;
&#xD;
        5. week: physical activity level (PAL) 1.6, 2 intervention days in the metabolic chamber:&#xD;
           isocaloric diet, isocaloric diet + ketone body supplements (isocaloric)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 21, 2020</start_date>
  <completion_date type="Actual">July 23, 2021</completion_date>
  <primary_completion_date type="Actual">July 23, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>all subjects are undergoing each intervention</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>appetite control - ghrelin</measure>
    <time_frame>24 hours</time_frame>
    <description>ghrelin concentration in plasma (24 hour AUC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>appetite control - GLP-1 concentration in plasma</measure>
    <time_frame>24 hours</time_frame>
    <description>Glucose Like Peptide-1 concentration in plasma (24 hour AUC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>appetite control - PYY concentration in plasma</measure>
    <time_frame>24 hours</time_frame>
    <description>Peptide YY concentration in plasma (24 hour AUC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>appetite control - subjective feelings of hunger</measure>
    <time_frame>24 hours</time_frame>
    <description>measured with visual analogue scales (24 hour AUC). The scale consists of a 10 cm vertical line anchored with &quot;not hungry at all&quot; at the left side and with &quot;extremely hungry&quot; at the right side.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>appetite control - satiety quotient</measure>
    <time_frame>30 min</time_frame>
    <description>satiety quotient of standard test-breakfast after 24 hours of intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>macronutrient oxidation</measure>
    <time_frame>24 hours</time_frame>
    <description>measured with indirect calorimetry in a metabolic chamber</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>energy expenditure</measure>
    <time_frame>24 hours</time_frame>
    <description>measured with indirect calorimetry in a metabolic chamber</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glycemia - glucose AUC</measure>
    <time_frame>24 hours</time_frame>
    <description>glucose AUC from continuous glucose monitoring data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>repeatability of energy expenditure measurements</measure>
    <time_frame>24 hours</time_frame>
    <description>repeated measurement of 24h-energy expenditure in a metabolic chamber on inactive isocaloric and fasting days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ß-Hydroxybutyrate concentration in serum</measure>
    <time_frame>24 hours</time_frame>
    <description>24 hour ß-Hydroxybutyrate concentration in serum (AUC)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>fasting, active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>36 hours fasting, PAL 1.6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ketogenic diet, active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 hours of ketogenic diet (liquid meals), PAL 1.6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>exogeneous ketone bodies, active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 hours of ketone body supplements (Beta-Hydroxybutyrate as Ca-Mg-salt) additional to a normal diet (liquid meals), PAL 1.6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fasting, inactive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>36 hours fasting, PAL 1.3</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Beta-Hydroxybutyrate as Ca-Mg-salt, active</intervention_name>
    <description>24 hour intervention with ketone body supplements additional to a normal diet (isocaloric diet in total) to induce ketosis (exogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.</description>
    <arm_group_label>exogeneous ketone bodies, active</arm_group_label>
    <arm_group_label>fasting, active</arm_group_label>
    <arm_group_label>fasting, inactive</arm_group_label>
    <arm_group_label>ketogenic diet, active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ketogenic diet (KetoCal® 4:1 Neutral, Nutricia GmbH, Erlangen, Germany), active</intervention_name>
    <description>24 hour interventions with ketogenic isocaloric diet to induce ketosis (endogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.</description>
    <arm_group_label>exogeneous ketone bodies, active</arm_group_label>
    <arm_group_label>fasting, active</arm_group_label>
    <arm_group_label>fasting, inactive</arm_group_label>
    <arm_group_label>ketogenic diet, active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>fasting, active</intervention_name>
    <description>36 hours of fasting, in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.</description>
    <arm_group_label>exogeneous ketone bodies, active</arm_group_label>
    <arm_group_label>fasting, active</arm_group_label>
    <arm_group_label>fasting, inactive</arm_group_label>
    <arm_group_label>ketogenic diet, active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>fasting, inactive</intervention_name>
    <description>36 hours of fasting, in a metabolic chamber at physical activity level of 1.3, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.3.&#xD;
The same intervention is reproduced one week later.</description>
    <arm_group_label>exogeneous ketone bodies, active</arm_group_label>
    <arm_group_label>fasting, active</arm_group_label>
    <arm_group_label>fasting, inactive</arm_group_label>
    <arm_group_label>ketogenic diet, active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy&#xD;
&#xD;
          -  BMI 19-29 kg/m2&#xD;
&#xD;
          -  low-medium habitual physical activity&#xD;
&#xD;
          -  women using hormonal contraceptive&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smoking&#xD;
&#xD;
          -  chronic illnesses&#xD;
&#xD;
          -  food allergies / intolerances&#xD;
&#xD;
          -  vegans and vegetarians&#xD;
&#xD;
          -  regular high physical activity (exercise &gt;1 hour/d)&#xD;
&#xD;
          -  current weight loss diet / weight loss of &gt;5 kg in the last 3 months&#xD;
&#xD;
          -  pregnant / lactating women&#xD;
&#xD;
          -  persons incapable of giving informed legal consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anja Bosy-Westphal, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Human Nutrition, Kiel University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Human Nutrition</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 16, 2020</study_first_submitted>
  <study_first_submitted_qc>July 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Kiel</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Dr. Anja Bosy-Westphal</investigator_full_name>
    <investigator_title>Prof. Anja Bosy-Westphal, PhD, MD</investigator_title>
  </responsible_party>
  <keyword>ketone bodies</keyword>
  <keyword>appetite control</keyword>
  <keyword>macronutrient oxidation</keyword>
  <keyword>metabolic chamber</keyword>
  <keyword>exogenous ketones</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

